RTI Surgical (RTIX) Receiving Somewhat Positive Media Coverage, Study Finds

Media coverage about RTI Surgical (NASDAQ:RTIX) has been trending somewhat positive on Thursday, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. RTI Surgical earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave media stories about the medical equipment provider an impact score of 46.6825516168977 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

Shares of RTI Surgical (NASDAQ:RTIX) traded down $0.05 during trading hours on Thursday, reaching $4.45. The company’s stock had a trading volume of 61,800 shares, compared to its average volume of 128,600. The firm has a market capitalization of $258.86, a price-to-earnings ratio of -63.57, a PEG ratio of 2.00 and a beta of 1.76. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.34 and a quick ratio of 1.21. RTI Surgical has a 12 month low of $3.01 and a 12 month high of $6.00.

RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. The company had revenue of $66.69 million during the quarter, compared to analyst estimates of $65.63 million. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. RTI Surgical’s quarterly revenue was up .2% compared to the same quarter last year. research analysts predict that RTI Surgical will post 0.05 EPS for the current year.

Several brokerages have commented on RTIX. BidaskClub lowered RTI Surgical from a “sell” rating to a “strong sell” rating in a research note on Thursday, December 14th. Zacks Investment Research lowered RTI Surgical from a “hold” rating to a “sell” rating in a research note on Thursday, October 5th.

TRADEMARK VIOLATION WARNING: This report was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at https://ledgergazette.com/2018/01/18/rti-surgical-rtix-receiving-somewhat-positive-media-coverage-study-finds.html.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Insider Buying and Selling by Quarter for RTI Surgical (NASDAQ:RTIX)

Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply